BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16334791)

  • 1. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of graft versus host disease of the liver.
    Quaglia A; Duarte R; Patch D; Ngianga-Bakwin K; Dhillon AP
    Histopathology; 2007 May; 50(6):727-38. PubMed ID: 17493237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
    Strasser SI; Shulman HM; Flowers ME; Reddy R; Margolis DA; Prumbaum M; Seropian SE; McDonald GB
    Hepatology; 2000 Dec; 32(6):1265-71. PubMed ID: 11093733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
    Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitic pattern of graft versus host disease in children.
    MelĂ­n-Aldana H; Thormann K; Duerst R; Kletzel M; Jacobsohn DA
    Pediatr Blood Cancer; 2007 Oct; 49(5):727-30. PubMed ID: 17066458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
    Kumar S; Wolf RC; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR
    Bone Marrow Transplant; 2002 Aug; 30(3):161-5. PubMed ID: 12189534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
    Kanamaru A; Takemoto Y; Kakishita E; Dohy H; Kodera Y; Moriyama Y; Shibata A; Kasai M; Katoh S; Saitoh H
    Bone Marrow Transplant; 1995 Jun; 15(6):885-9. PubMed ID: 7581086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children.
    Patey-Mariaud de Serre N; Reijasse D; Verkarre V; Canioni D; Colomb V; Haddad E; Brousse N
    Bone Marrow Transplant; 2002 Feb; 29(3):223-30. PubMed ID: 11859394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for the treatment of chronic graft-versus-host disease.
    Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR
    N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
    Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.
    Iqbal M; Creger RJ; Fox RM; Cooper BW; Jacobs G; Stellato TA; Lazarus HM
    Bone Marrow Transplant; 1996 Apr; 17(4):655-62. PubMed ID: 8722371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
    Barshes NR; Myers GD; Lee D; Karpen SJ; Lee TC; Patel AJ; Finegold M; Goss JA
    Liver Transpl; 2005 May; 11(5):525-31. PubMed ID: 15838886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.